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Abstract
Creatine kinase catalyzes the reversible transfer of the N-phosphoryl group from phosphocreatine to ADP to generate ATP
and plays a key role in highly energy-demanding processes such as muscle contraction and flagellar motility; however, its
role in signal transduction (which frequently involves ATP-consuming phosphorylation) and consequent cell-fate decisions
remains largely unknown. Here we report that creatine kinase B was significantly up-regulated during the differentiation of
double-positive thymocytes into single-positive thymocytes. Ectopic expression of creatine kinase B led to increased ATP
level and enhanced phosphorylation of the TCR signaling proteins. Consequentially, transgenic expression of creatine kinase
B promoted the expression of Nur77 and Bim proteins and the cell death of TCR signaled thymocyte. In addition, the
activation, proliferation and cytokine secretion of T cells were also enhanced by the expression of creatine kinase B
transgene. In contrast, treatment of T cells with specific creatine kinase inhibitor or creatine kinase B shRNA resulted in
severely impaired T cell activation. Taken together, our results indicate that creatine kinase B plays an unexpected role in
modulating TCR-mediated signaling and critically regulates thymocyte selection and T cell activation.
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Introduction
Intrathymic T cell development is critical for the establishment
of a properly functioning adaptive immune system. T cell
precursors generated in the bone marrow migrate to the thymus
where their TCR genes are rearranged and their fates are dictated
[1–3]. Thymocytes with defected TCR could not be signaled and
go into a process of apoptosis termed ‘‘death by neglect’’;
Thymocytes expressing TCR with high affinity for self peptide-
MHC molecules undergo negative selection and die locally in the
thymus, thus being eliminated from the T cell pool [4].
Conversely, thymocytes that express TCR with low affinity for
self peptide-MHC molecules receive survival signals, initiate
positive selection of the cells and give rise to mature CD4 or
CD8 T cells [5,6]. Through positive and negative selection, an
immunocompetent and self-tolerant T cell repertoire is generated
[7,8]. T cells that pass the selection leave the thymus and initiate
immune surveillance in peripheral tissues where they may
encounter their specific foreign antigen and become activated [9].
Stimulation of TCR by the peptide-MHC complex triggers a
cascade of phosphorylation and dephosphorylation events in a
spatially and temporally ordered manner in T cells [10–12],
during which immune-receptor tyrosine-based activation motifs
(ITAMs) of the CD3 molecules are phosphorylated by the Src-
family tyrosine kinase Lck, phosphorylated ITAMs then recruit
another tyrosine kinase Zap70 and facilitate the phosphorylation
of Zap70 by Lck, and in turn activated Zap70 phosphorylates the
adaptor proteins LAT and SLP-76 [11]. Phosphorylation of
tyrosine residues on LAT and SLP-76 results in recruitment of a
batch of other signaling proteins and subsequently leads to Ca
2+
mobilization and activation of multiple pathways, including ERK,
JNK, p38 and NF-kB pathways, which finally activate distinct
nuclear factors involved in thymocyte differentiation, T cell
proliferation and cytokine production [13–15].
The roles of various protein kinases in TCR signaling pathway
have become relatively clear after extensive studies [10,16–18].
Considering that all phosphorylation reactions catalyzed by these
protein kinases require ATP as the phosphoryl donor [17,19], it is
likely that the intracellular ATP concentration and the ATP
regeneration capacity of T cells have a strong impact on TCR
signal strength. In fact, for different subsets of T-lineage cells at
distinct developmental stages, their requirements of TCR signaling
and competence to transduce TCR signal are quite different,
which may be partially fulfilled by modulating their cellular ATP
level. However, the generation, storage and usage aspects of ATP
in T-lineage cells have been poorly investigated up to date.
The cellular ATP pool is relatively constant but ATP itself is
rather unstable. It has been reported that creatine kinase (CK)
helps keep the ATP pool constant through catalyzing the
reversible transfer of the phosphoryl group from phosphocreatine
(PCr) to adenosine 59-diphosphate (ADP) [20–22]. CK genes are
expressed in several tissues with highly fluctuating energy
turnover, e.g. skeletal and cardiac muscle, brain and spermatozoa
[23,24]. Several isoenzymes of CK have been characterized:
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isoenzymes (Ckmt1 and Ckmt2). It has been reported that
dysregulated CK is associated with many diseases, such as heart
disease, mental diseases, cancer and inflammatory diseases [25–
29]. Despite that the properties and functions of CK in energy-
demanding processes have been investigated extensively, its role in
specific cellular signal transduction and consequential cell fate
decisions remains largely unknown.
In attempt to obtain a better understanding of thymocyte
development, we had used cDNA microarray technique to screen
genes potentially involved in this process. Ckb was found to be
stage-specifically expressed by this approach and was chosen for
this study considering it directly participates in the regulation of
ATP generation. Here we show that the expression levels of Ckb in
double-positive (DP) thymocytes, single-positive (SP) thymocytes
and T cells are marginal, high and median respectively, which is in
accordance with their cellular ATP levels. We further show that
ectopic expression of Ckb results in increased ATP level and
enhanced TCR signaling, and transgenic expression of Ckb
promotes premature thymocyte death and enhances T cell
proliferation and cytokine production. And importantly, Suppres-
sion of Ckb activity by specific inhibitor or RNA interference
attenuates TCR signaling and inhibits T cell activation. These
data identify Ckb as an important regulator of T cell development
and activation by tuning TCR signal strength.
Results
Ckb is stage-specifically expressed in T-lineage cells
Previous microarray analysis (GEO database, GSE2262)
revealed that the transcription of Ckb was significantly higher in
CD69
high thymocytes (comprising TCR signaled DP, CD4SP and
CD8SP thymocytes) than in CD69
low thymocytes (unsignaled DP
thymocytes only) [30]. Consistent with this observation, Western
blot analysis showed about 18-fold increase in Ckb protein
abundance from DP to CD4SP subsets, while surprisingly there
was a about 1.5-fold decrease from CD4SP to CD4 T cell subsets
(Figure 1A); similar expression pattern of Ckb was found in CD8-
lineage cells. Intracellular staining was further used to depict the
Ckb expression pattern in T-lineage cells. As shown in Figure 1B,
DP thymocytes had the lowest Ckb expression, SP thymocytes had
the highest expression level and expression in T cells was in the
middle. Considering CK is a key enzyme that catalyzes ATP
generation, the relative levels of ATP were next measured in the
purified subsets. In accordance with the expression level of Ckb,
the ATP concentration was lowest in DP thymocytes, highest in
CD4SP and CD8SP thymocytes and middle in CD4 and CD8 T
cells (Figure 1C).
Since Ckb expression was up-regulated along with the
maturation of SP cells, we wondered if TCR signaling could
directly promote Ckb expression. As shown in Figure 1D, the
expression of Ckb was not enhanced in thymocytes and T cells
after stimulation with anti-TCR or anti-TCR and anti-CD28
respectively; while CD69, as a positive control, was greatly up-
regulated upon stimulation (Figure S1), suggesting that Ckb is not
a direct target of TCR signaling. We also compared the expression
levels of other CK isoenzymes between CD69
high and CD69
2/low
thymocytes, RT-PCR analysis of transcriptions showed that only
Ckb was differentially expressed (Figure 1E).
Transgenic expression of Ckb promotes ATP generation
and enhances TCR signal strength
Since Ckb is differentially expressed and critical for ATP
metabolism, we speculated that it may participate in regulating
thymocyte development and T cell function. Considering that Ckb
is expressed at a low level at DP stage, overexpression model
would provide a useful tool to investigate its effects on thymocyte
selection. To this end, we generated Ckb transgenic (CkbTg) mice
using a wild-type Ckb cDNA under the transcriptional control of
human CD2-based regulatory elements, which conferred ectopic
expression of Ckb in T-lineage cells. As shown in Figure 2A and
Figure S2, the expression level of transgenic Ckb in DP
thymocytes is similar to that of the endogenous Ckb in CD4SP
thymocytes from littermate controls.
We then ascertained whether transgenic Ckb is functional, the
total CK activity was measured and the results indicated that the
CK activity was much higher in transgenic cells than in control
counterparts (Figure 2B). Previous studies suggest that CKs mainly
function to accelerate the rates of high energy phosphate exchange
between PCr and ATP rather than increase intracellular ATP level
[31]. However, we observed that the ATP level was increased by
1.6-fold in transgenic DP thymocytes and 1.4-fold in transgenic T
cells compared with control cells respectively (Figure 2C). We then
asked whether transgenic expression of Ckb affects TCR signaling,
as shown in Figure 2D, the magnitude of tyrosine phosphorylation
of either total cellular proteins (Top panel) or Lck and Zap70
(Middle panel) was measurablely enhanced, and the phosphory-
lation of p38, JNK and Erk1/2 was substantially increased in
CkbTg DP thymocytes relative to their littermate counterparts in
the presence of TCR stimulation (Bottom panel). Consistent with
the above observations, TCR-induced Ca
2+ mobilization was also
enhanced in CkbTg DP thymocytes (Figure 2E). To further
examine whether the CkbTg thymocytes were better signaled
under the de facto situation, we measured the activation markers
on the DP thymocyte surface. DP thymocytes from CkbTg mice
significantly up-regulated the expression of CD5, CD69 and CD25
compared with respective counterparts from littermates
(Figure 2F).
Early expression of Ckb leads to loss of premature DP
thymocytes
To examine if the transgenic expression of Ckb altered
thymocyte development, cell numbers were determined and the
results showed that the total thymic cellularity of CkbTg mice was
reduced approximately by half (Figure 3A, left). We next analyzed
thymocyte populations by staining of CD4 and CD8 surface
markers, compared with nontransgenic littermates, CkbTg mice
showed a decrease in the proportion of DP and CD4SP
thymocytes and an increase in the proportions of the other subsets
(Figure 3B). Statistically, the observed drop in cellularity mainly
came from DP subset, which reduced about two thirds in
transgenic mice compared to littermates (Figure 3A, right). The
decrease in DP cellularity in CkbTg thymus may be due to defects
in early DN development, analysis of the distribution, TCRb
expression and viability of DN subsets showed that these events
were comparable between CkbTg thymocytes and their littermate
counterparts (Figure 3, C, D and E), indicating that TCR b
selection is normal in CkbTg mice. To evaluate the maturity of
CD4 and CD8 SP thymocytes in CkbTg mice, the expression of
TCR and heat-stable antigen (HSA) was analyzed and no
significant difference was detected between CkbTg and littermate
SP thymocytes (Figure 3F).
Enforced expression of Ckb enhances the apoptosis of
TCR signaled thymocytes
According to the above results, the loss of DP thymocyte in
CkbTg mice is likely due to increased cell death. Indeed, we found
Ckb Modulates TCR Signaling
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5000Figure 1. The expression profiles of Ckb in T-lineage cells. (A) The expression of Ckb in purified cells was analyzed by immunoblot with a
rabbit polyclonal antibody against Ckb and the optical density of the bands was quantified and normalized against that of b-actin. (B) Flow
cytometric analysis of Ckb expression in thymocytes and T cells. DP thymocytes stained with pre-serum was used for negative control (DP Ctrl). (C)
The relative intracellular ATP concentration was measured in purified DP, CD4SP, CD8SP thymocytes and CD4, CD8 T cells (*, P,0.05). (D) Total
thymocytes and lymphocytes were stimulated with anti-TCR (10 mg/ml) or anti-TCR (10 mg/ml) and anti-CD28 (10 mg/ml) respectively for 6 h or 12 h
or unstimulated (Unsti-) and then analyzed for Ckb expression. (E) RT-PCR analysis showed that only Ckb is differentially expressed during thymocyte
development. CD69
high and CD69
2/low thymocytes were sorted from C57BL/6 mice. Bands resolved on agarose gels show PCR products by 5-fold
serial dilution of cDNA (wedges), numbers of PCR cycles used for amplification were written underneath the gene name. ckmt2 was not detectable in
these two subsets. All the results above are representative of three independent experiments.
doi:10.1371/journal.pone.0005000.g001
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in vivo as detected by annexin V and propidium iodide (PI)
staining, an approximately 1.5-fold increase in early apoptotic
(Annexin V
+PI
2) DP thymocytes was detected in CkbTg mice
compared with that of their littermate controls (Figure 4A). The
enhanced apoptotic thymocytes in CkbTg mice were further
confirmed by TUNEL assay (Figure 4B). Since CkbTg DP
thymocytes were hyperactivated (Figure 2, D–F), we assumed that
enhanced apoptosis of DP thymocytes in CkbTg mice was caused
by activated cell death rather than death by neglect. To test this
possibility, we first assessed CkbTg thymocytes for the expression
of antiapoptotic Bcl-2 molecule, which was normally up-regulated
in signaled DP thymocytes to protect thymocytes from death by
neglect [32], as shown in Figure 4C, CkbTg DP thymocytes
Figure 2. Transgenic Ckb promotes ATP generation and augments TCR signal strength. (A) Expression of Ckb protein was analyzed by
immunoblot analysis of lysates from total thymocytes or lymphocytes, b-actin served as a loading control. (B) Creatine kinase activity in cell extracts
was determined by using standard methods as described in Materials and Methods (*, P,0.05). (C) Detection of intracellular ATP concentration of
beads-purified cells (*, P,0.05). (D) Analyses of phosphorylation of proteins involved in TCR signaling. FACS-purified DP thymocytes were left
unstimulated or stimulated by anti-TCR plus anti-CD4 streptavidin-mediated crosslinking for 2 min, Shown on the top are tyrosine phosphorylation of
total cellular proteins, membrane was stripped and reprobed for Zap70 as a loading control; Shown on the middle are tyrosine phosphorylation of
Lck and Zap70, equal loading of the lanes was verified by anti-Zap70 immunoblotting; Phosphorylation of p38, JNK and Erk1/2 is shown on the
bottom, membranes were stripped and reprobed for ERK1/2 as a loading control. (E) TCR-induced Ca
2+ mobilization. Shown are the histograms of
Ca
2+ mobilization in control cells (gray line) and CkbTg (black line) DP thymocytes. Thymocytes were stimulated with biotin-conjugated anti-TCR and
anti-CD4, cross-linked with streptavidin, and analyzed for Ca
2+ mobilization. Arrows indicate the time points when straptavidin was added. (F) Flow
cytometric analysis of the expression of CD5, CD69 and CD25 on DP thymocytes. The results are representative of three to four independent
experiments. Litt, littermate; CkbTg, Ckb transgenic mouse.
doi:10.1371/journal.pone.0005000.g002
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then compared the difference in apoptosis of TCR signaled
(CD69
high) and unsignaled (CD69
2/low) DP thymocytes from
CkbTg and control mice respectively and found that the difference
was greater in the comparison of CD69
high cells than in that of
CD69
2/low cells (Figure 4D), which indicated that specific deletion
was occurred after TCR triggering. In addition, we analyzed the
expression of orphan nuclear receptor Nur77 and the proapoptotic
protein Bim, which are crucial mediators of negative selection
[33,34], by using the same subsets as used in the above
experiment. Interestingly, Immunoblot revealed that the expres-
sion of Nur77 and Bim was up-regulated in CkbTg thymocytes
and greater difference was found between CD69
high DP
thymocytes than between CD69
2/low DP thymocytes (Figure 4E),
indicating that more TCR signaled thymocytes were undergoing
negative selection in transgenic mice.
We then asked whether the enhanced negative selection of
CkbTg thymocytes is mediated by the altered TCR signal strength,
to address this issue, we stimulated thymocytes with plate-bound
anti-TCR and anti-CD28 to mimic negative selection in vitro [35].
Figure 3. Flow cytometric analysis of thymocyte populations. (A) Comparison of thymocyte subsets in Ckb-transgenic mice and littermate
controls. Bar graphs (error bars: SEM) indicate the average numbers of each thymocyte subset. The results were summarized from 4- to 5-week-old
Ckb-transgenic mice (n=5) and littermate control mice (n=5) (*, P,0.05). (B) Dot plots indicate CD4 versus CD8 profiles of live thymocytes, numbers
next to boxes indicate the percentage of cells in that box. (C) The relative distribution of DN subsets revealed by CD44 and CD25 staining. (D)
Intracellular staining for TCRb expression in DN3 and DN4 thymocytes, Numbers on the graphs represent the percentage of TCRb positive cells. (E)
Freshly isolated thymocytes were stained with anti-CD4 and anti-CD8, followed by dual-labeling for annexin V and PI and analyzed by flow cytometry,
the percentages of cells within each quadrant are shown in the upper left quadrants. (F) Detection of TCR and HSA expression on CD4SP and CD8SP
thymocytes from CkbTg mice and littermate controls. The results are representative of three to fiver independent experiments. Litt, littermate; CkbTg,
Ckb transgenic mouse.
doi:10.1371/journal.pone.0005000.g003
Ckb Modulates TCR Signaling
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clearly detectable by Annexin V versus PI staining, however, more
apoptotic cells were detected in CkbTg DP thymocytes than in
control DP thymocytes from two separate experiments, suggesting
that the enhanced negative selection induced by transgenic
expression of Ckb is TCR signaling-dependent.
To examine the influence of transgenic expression of Ckb on
positive selection in the thymus, OT-1(MHC Class I-restricted)
and AND (MHC class II-restricted) TCR transgenic mice were
separately crossed to the CkbTg mice. Normally, the OT-1 or
AND TCR transgenic thymocytes express the same MHC
restricted TCR and undergo positive selection of CD8 and CD4
T cells respectively. Intriguingly, on Ckb transgenic background,
positive selection of TCR transgenic thymocytes was greatly
impaired as evidenced by the dramatically decreased number of
both DP and SP thymocytes (Figure 5, A and B). Notably, the Ckb
and TCR double transgenic DP thymocytes expressed CD5 and
CD69 at slightly lower levels (Figure S3), which might reflect quick
death of CD5
high and CD69
high cells, they had higher CD25
expression compared with their counterparts from single TCR
Figure 4. Transgenic expression of Ckb promotes premature death of DP thymocyte. (A) Apoptotic and dead DP thymocytes were
discriminated on the basis of a double-labeling for annexin V and PI and analyzed by flow cytometry, the percentages of cells within each quadrant
are shown in the upper left quadrants. (B) Apoptotic DP thymocytes were measured by TUNEL assay (Ctrl, TUNEL reaction mixture without TdT
enzyme solution; *, P,0.05). Thymocytes used in both (A) and (B) were freshly prepared. (C) Flow cytometric analysis of Bcl-2 expression in DP
thymocytes. (D) Flow cytometric analysis of apoptotic CD69
2/low and CD69
high DP thymocytes from CkbTg mice and their littermate controls using
Annexin V and PI staining. The percentages of cells within each quadrant are shown in the upper left quadrants, N/A, not applicable. (E) Immunoblot
analysis of Bim and Nur77 expression in FACS-sorted CD69
2/low and CD69
high DP thymocytes, b-actin served as a loading control. (F) Thymocytes
were stimulated with different concentrations of plate-bound anti-TCR and anti-CD28 antibodies for 12 h and then used for apoptotic analysis (Top,
anti-TCR (H57-597) 1 mg/ml, anti-CD28 (37.51) 1 mg/ml. Bottom, anti-TCR (H57-597) 10 mg/ml, anti-CD28 (37.51) 10 mg/ml), the percentages of cells
within each quadrant are shown in the upper left quadrants. Data are representative of three independent experiments. Litt, littermate; CkbTg, Ckb
transgenic mouse.
doi:10.1371/journal.pone.0005000.g004
Ckb Modulates TCR Signaling
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Bim was up-regulated in the Ckb and TCR double transgenic
thymocytes(Figure5D).These data revealthattransgenicexpression
of Ckb promoted TCR-mediated apoptosis and thus contributed to
increased premature thymocyte death in CkbTg thymus.
Ectopic Ckb expression augments T cell activation
In contrast to the population variation found in the thymus, the
relative proportions and absolute numbers of peripheral CD4 and
CD8 T cell were similar between transgenic and littermate mice
(Figure S4). Given the positive impact of Ckb on TCR signal
transduction, we next examined whether Ckb participates in the
regulation of T cell activation. As shown in Figure 6 A and B,
compared with their littermate counterparts, CkbTg T cells
expressed high levels of CD25 and proliferated strongly after
stimulation with immobilized anti-TCR and anti-CD28 antibod-
ies. Furthermore, the induction of IL-2 and IFN-c was analyzed by
intracellular staining after stimulation with PMA and IM as
described [36], as shown in Figure 6C, both the mean fluorescence
intensity (MFI) and the frequency of IL-2 and IFN-c were
increased in CkbTg T cells. Taken together, the above results
indicate that Ckb protein significantly improves TCR signaling
capacity and suggest that Ckb plays an important role in T cell
activation.
Figure 5. Ectopic expression of Ckb impairs thymic positive selection. (A, B) Dot plots indicate CD4 versus CD8 profiles of total thymocytes
from TCR transgenic or Ckb and TCR double transgenic mice, numbers next to boxes indicate the percentage of cells in that box. The cell numbers of
total thymocytes or different subsets are shown on the right. (A), MHC Class I restricted OT-1 TCR transgenic; (B) MHC Class II restricted AND TCR
transgenic (*, P,0.05). (C) Detection of surface CD25 expression on DP thymocytes. (D) Immunoblot analysis of Bim and Nur77 expression in total
thymocytes, b-actin served as a loading control. Litt, littermate; CkbTg, Ckb transgenic mouse.
doi:10.1371/journal.pone.0005000.g005
Ckb Modulates TCR Signaling
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stimulation
Finally, we examined whether Ckb is necessary for T cells to
response properly. To achieve this, T cells were stimulated with
anti-TCR and anti-CD28 antibodies in the absence or presence of
cyclocreatine (cCr), one of the most kinetically active analog of
creatine. Both cCr and creatine are substrates for CK and have
been shown to modulate rates of ATP production, cCr was widely
Figure 6. Ecotopic expression of Ckb enhances TCR sensitivity and T cell response. (A) Flow cytometric analysis of the activation marker
CD25 on CD4 and CD8 T cells, cells were stimulated with plate-bound anti-TCR (10 mg/ml) and anti-CD28 (10 mg/ml) antibodies or left unstimulated
for 16 h. (B) CFSE-labeled lymphocytes were stimulated with plate-bound anti-TCR (top 0.5 mg/ml, bottom 2 mg/ml) and anti-CD28 antibodies (top
0.5 mg/ml, bottom 2 mg/ml) or left unstimulated. Cells aliquots were analyzed for CFSE fluorescence as an indicator of cell division. Analyses were
gated on CD4
+ or CD8
+ cells as indicated. (C) Analysis of cytokine expression. LN T cells were isolated from 6-week-old CkbTg and Littermate mice, left
unstimulated or stimulated with PMA and IM for 4 h and then analyzed for CD4, CD8, IL-2 and IFN-c expression. Values in the gating boxes indicate
the percentage of IL-2
+ or IFN-c
+ cells and numbers underneath the gating boxes indicate the MFI of IL-2 and IFN-c. The results are representative of
three independent experiments. Litt, littermate; CkbTg, Ckb transgenic mouse.
doi:10.1371/journal.pone.0005000.g006
Ckb Modulates TCR Signaling
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[37–40]. Cell viability was not affected in the presence of cCr (data
no shown); however, the CD25 expression and proliferation of T
cells were greatly impaired (Figure 7, A and B). In addition, by
using the same approach described in Figure 6C, we found that
the synthesis of IL-2 and IFN-c was down-modulated in cCr
treated T cells compared with those without treatment after PMA
and IM stimulation (Figure 7C). RNA interference (RNAi)
technology was further used to address the effect of depletion of
endogenous Ckb on T cell activation. As shown in Figure 7D, the
functional Ckb shRNA oligonucleotides effectively knocked down
the expression of Ckb, accordingly, the response of transfected T
cells to TCR stimulation was substantially attenuated as indicated
by CD25 expression (Figure 7E). Although whether the impaired
T cell activation was resulted from altered TCR signaling alone or
in combination with other pathways is unclear here because ATP
is pivotal for the phosphorylation reactions in general, we conclude
that intact Ckb activity is important for full T cell activation from
the above observations.
Discussion
It is well known that CKs play key roles in energy metabolism in
high energy-consuming tissues like brain and skeletal muscle
through providing a temporal and spatial ATP buffer to maintain
cellular energy homeostasis [20,21]. While cellular ATP is used
not only for fitting the fluctuating energy demands, but also for
many other biological events, such as protein phosphorylation,
cAMP generation and so on. Tissue specific and developmentally
regulated CKs may integrate metabolic and apoptotic signals to
mount other cellular response besides muscle contraction and
neuron function [24,38,41,42]. In this study, we have demon-
strated an unexpected role of Ckb in regulating thymocyte
development and T cell activation via modulating TCR signal
strength.
Consistent with the observation that cytosolic isoenzymes of
CK, as a catalyzer, mainly promote ATP generation rather than
ATP consumption [43], we found CkbTg thymocytes and T cells
had more ATP than their control counterparts (Figure 2C). By
using cell-based assays, we showed that CkbTg DP thymocytes
were TCR-signaled greater than their littermate counterparts
(Figure 2, D–F), which might be not only induced by the
increased ATP level but also the enhanced ability to buffer the
ATP pool due to the ectopic expression of Ckb. Moreover,
CkbTg T cells were found to be hypersensitive to TCR
stimulation as evidenced by enhanced cytokine production and
proliferation (Figure 6), on the other hand, T cell activation was
greatly down-regulated when Ckb expression was silenced or its
enzymic activity was blocked (Figure 7). Therefore, our results
indicated that Ckb plays an important role in determining signal
strength from the TCR.
The differentiation of DP thymocytes into CD4 or CD8 SP cells
in the thymus is necessary for the establishment of immunocom-
petence of the cells, which is accomplished by reprogramming of a
complex array of gene expression to fulfill diverse biological
functions, including up-regulation of the antiapoptotic Bcl-2 for
survival and of the IL-2Ra chain for cell proliferation [12,44].
Previous reports showed that glucose transporter molecules are up-
regulated during the thymocyte maturation, which improve
nutrient uptake and increase metabolic activity and thus to
provide the metabolic energy needed to activate new genetic
programs [45,46]. Here we report that Ckb, a novel metabolic
regulator of T lineage cells, plays a critical role in modulating
immune responses such as cell proliferation and cytokine secretion.
Considering that TCR signals induce a serial of protein
phosphorylation reactions, Ckb could work as an ‘‘amplifier’’
to enhance TCR signaling in multiple points through rapid
providing cellular ATP, which finally leads to turn-on of specific
factors for immune function in response to pathogen infection.
Therefore, the up-regulation of Ckb expression from premature
DP thymocytes to functionally mature SP and T cells may well
be important for T cells to elevate their sensitivity to the limited
foreign antigen.
We have noted that Ckb is more highly expressed by CD4SP
thymocytes than CD8SP thymocytes, whether Ckb participates in
regulating CD4/CD8 lineage decision is not directly addressed
here, however, the CD4SP/CD8SP ratio in CkbTg mice differed
from that in littermate mice (Figure 3B), which indicates altered
lineage commitment. Intriguingly, we found that early expression
of Ckb strongly promotes activated thymocyte death due to the
enhanced TCR signaling, suggesting that Ckb is involved in this
process. Another interesting feature is that Ckb is expressed at
highest level in SP thymocytes and at relatively low level in T cells
(Figure 1, A and B), this unique expression pattern may well
facilitate the establishment of central T cell tolerance. The process
of negative selection of thymocytes initiates as early as DP stage
and will prolong to SP stage [8,47]. At SP stage, the TCR signal
strength is greatly enhanced due to the highest Ckb expression
(rapid ATP regeneration and relative high ATP level), thus, the
auto-reactive thymocytes are terminally proofread at this check-
point and ultimately lead to activated cell death; and importantly,
T cells that pass selection will down-regulate Ckb, and thereafter
avoid being hyperreactive to self antigen in the periphery.
In this study, we have focused on the impact of Ckb on TCR
signal strength, we demonstrated that Ckb tunes the threshold of
TCR signaling leading to thymic selection and T cell proliferation;
whether and how Ckb regulates other signaling pathways such as
cytokine and chemokine pathways were not investigated. Ckb may
also have similar impact on these signals, and future experiments
will strive to address these issues.
Materials and Methods
Mice
C57BL/6, OT-1 and AND TCR transgenic mice were
obtained from The Jackson Laboratory. CkbTg mice were
generated by over-expression of Ckb under control of the human
CD2 promoter and locus control region in the transgenic
expression vector p29g2 (gift of Paul Love), two transgenic
founders with similar phenotype were generated and one line was
used in this study. Mice were maintained in SPF facility and
analyzed between 5 and 10 weeks of age. All animal experiments
were approved by the institutional animal use committee of the
Shanghai Institutes for Biological Sciences, Chinese Academy of
Sciences.
Antibodies and reagents
The following monoclonal antibodies were from BD-Pharmin-
gen: anti-TCRb (H57-597), anti-CD4 (RM4.4 and GK1.5), anti-
CD5 (53-7.3), anti-CD8a (53-6.7), anti-CD28 (37.51), anti-CD69
(H1.2F3), anti-TCR Vb5 (B20.1), anti-Va11 (RR8-1), anti-CD25
(2A3), anti-HSA (M1/69), anti-Bcl-2 (100) and anti-Nur77 (12.14).
Anti-Erk1/2 (sc-154), anti-Bim (sc-11425), anti-phospho-Erk1/2
(sc-16981-R) and anti-phospho-P38 (sc-17852-R) were from Santa
Cruz Biotechnologies. Anti-phospho-JNK(Thr183/Tyr185) was
from Cell Signaling Technology, Inc. Polyclonal rabbit anti-
mouse Ckb antibody was generated by our lab. In brief, Ckb
fragment (encoding 1–143 amino acids of mouse Ckb) was
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vector and GST-fusion protein was expressed according to the
manufacturers’ protocols. The purified GST fusion protein was
used as the antigen to immunize rabbits for generation of anti-Ckb
polyclonal antibodies according to standard protocol. cyclocrea-
tine (cCr) was purchased from Sigma-Aldrich.
Figure 7. Suppression of Ckb activity attenuates TCR-mediated responses in T cells. (A) Flow cytometric analysis of CD25 expression on
CD4 and CD8 T cells, cells were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies (10 mg/ml each) with or without cCr or left
unstimulated for 12 h, cCr were used at 50 mM. (B) Proliferation of CFSE-labeled lymphocytes was detected as described in Figure 6B. To be note, the
concentration of cCr was 25 mM and the concentration of anti-CD3 and anti-CD28 is 5 mg/ml each. (C) Analysis of cytokine production, cell were treat
with or without cCr (50 mM) for 12 h, then left unstimulated or stimulated with PMA and IM for 4 h and analyzed for CD4, CD8, IL-2 and IFN-c
expression. Values in the gating boxes indicate the percentage of IL-2
+ or IFN-c
+ cells and numbers underneath the gating boxes indicate the MFI of
IL-2 and IFN-c. (D) Down-regulation of Ckb expression by lentiviral-mediated RNA interference. T cells were infected with either control (Ctrl) or Ckb-
specific shRNA (shRNA), cells were then sorted on the basis of GFP expression and GFP positive (effectively infected) cells were subjected to
Immunoblot analysis with Ckb antibodies, the optical density of the bands was quantified and normalized against that of b-actin. (E) Flow cytometric
analysis of CD25 expression on T cells. T cells were infected with either control or Ckb-specific shRNA and then stimulated with plate-bound anti-TCR
and anti-CD28 antibodies (10 mg/ml each). Analyses were gated on GFP
2 (uninfected) or GFP
+ (infected) cells. The results are representative of two to
three independent experiments.
doi:10.1371/journal.pone.0005000.g007
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Thymocyte and lymphocyte suspensions were prepared and
were stained for the expression of cell surface markers as described
[48]. A two-laser FACSCalibur (BD Biosciences) with four-decade
logarithmic amplification was used for flow cytometry analysis,
typically on 3610
5 cells/sample. Cells were stained for intracel-
lular Ckb or Bcl-2 after 10 min fixation (2% formaldehyde PBS,
room temperature) and 5 min permeabilization in IC staining
buffer (0.03% saponin, 0.1% BSA, 0.1% NaN3 in PBS). For
intracellular Bcl-2 staining, the cells were incubated sequentially
with PE-conjugated anti-mouse Bcl-2, followed by staining for cell
surface expression of CD4 and CD8. For the intracellular Ckb
staining, the cells were firstly incubated with anti-Ckb, and then
PE-conjugated anti-rabbit IgG, followed by cell surface staining.
Results were analyzed using FlowJo software (Treestar). Live cells
were identified by forward and side scatter or by propidium iodide
(PI) gating.
T cell proliferation, activation and apoptosis
T cell proliferation and stimulation were done as described
[30]. T cells were labeled with CFSE (Molecular Probes,
Eugene OR) at 1 mM in HBSS for 10 min at 37uC, washed
with RPMI containing 10% FCS, and were incubated on plates
coated with H57-597 and GK37.51 antibodies. For measure-
ment of cell apoptosis, freshly isolated thymocytes were three-
color stained with FITC-annexin V (Bender MedSystems), PE-
conjugated anti-CD8 antibody, and APC- conjugated anti-CD4
antibody. Apoptotic cells were detected with annexin V and PI
staining of the cells. For the activation of T cells, PMA and IM
were used at concentrations of 10 ng/ml and 10 mg/ml
respectively.
Determination of intracellular ATP level
DP, CD4SP thymocytes and CD4 T cells were isolated using
anti-CD4 (GK1.5), anti-CD8 (53-6.7) magnetic beads (Miltenyi
Biotec) as described [30]. Cellular ATP level was determined by
luciferin-luciferase-based assay. Aliquots containing 0.5610
6
purified thymocyte subsets or total thymocytes were processed
using the ATP Bioluminescence Assay kit (from Beyotime)
according to standard protocol.
Reverse transcription polymerase chain reaction (RT-PCR)
RT-PCR analyses were done as described [48]. PCR products
were separated by agarose gel electrophoresis and were visualized by
ethidium bromide staining. PCR primers used were as follows: Ckb
sense 59-ATCCATCGCCCCTGCTTCGT-39 and anti-sense 59-
GCTCATCACTGGGCTGGTAG-39;C k ms e n s e5 9-GTCACCA-
CCACCTCCACAGC-39 and anti-sense 59-ATGGCGGTCCTG-
GATGATGG-39; Ckmt1 sense 59-TGGGATACATTTTGACTT-
GCC-39 and anti-sense 59-TCATACCAGCAGACAGTTTACC-
39; Hprt sense 59-CCTGCTGGATTACATTAAAGCACTG-39
and anti-sense 59-TTCAACACTTCGAGAGGTCCT-39.
Lentivirus-mediated RNA interference
HIV lentiviral vector pLL3.7 for shRNA expression is prepared
as described previously [49]. The Ckb-specific-shRNA was
constructed and transfected into packaging cells to produce
retroviral supernatants (detailed procedures available on request).
1610
6 spleen cells were resuspended in 1 ml of retroviral
supernatant containing 20 mg polybrene (Chemicon Internation-
al), centrifuged at 1,000 g for 90 min at 25uC, and placed into
fresh media for 2 d. Cells were then stimulated with plate-bound
anti-TCR (10 mg/ml) and anti-CD28 (10 mg/ml) antibodies and
followed by flow cytometry analysis, the pLL3.7 vector was used as
control. The sense strand sequence of the Ckb shRNA is 59-
ACTACTCATTGAGATGGAG-39
Calcium flux assay
Thymocytes were preloaded with Fluo-3 AM at 5 mg/ml for
30 min at 37 uC, then surface stained with anti-CD8-APC as well
as biotinylated anti-TCR and anti-CD4 (1 mg/ml), finally washed
and resuspended (2610
6/ml) in HBSS and 2% FCS. After a
baseline was established at quiescence, Ca2
+ flux was induced by
the addition streptavidin (4 mg/ml) for cross-linking. The resultant
flux in Ca2+ was measured for 5 min by flow cytometry.
Intracellular cytokine production analysis
Flow-cytometric analysis of cytokine production was performed
as described [36]. Lymph node cells were stimulated in vitro with
PMA (10 ng/ml) and IM (10 mg/ml) for 4 h in the presence of
BFA (BD PharMingen). After culture, stimulated and unstimulated
control cells were fixed for 10 min in room temperature in 2%
formaldehyde. Then, cells were stained for surface expression of
CD4, CD8, and intracellular cytokine staining antibodies
according to the manufacturer’s (BD Biosciences) protocol.
TUNEL assay
TUNEL assay was performed using a kit (in situ cell death
detection kit with fluorescein; Roche Molecular Biochemicals)
according to the protocol provided by the manufacturer [50].
Briefly, 1610
6 thymocytes were fixed for 10 min (2% formalde-
hyde PBS, room temperature), and incubated with anti-CD4 and
anti-CD8 for cell surface staining. After permeabilization with IC
staining buffer, thymocytes were further incubated for 1 h at 37uC
with 50 ml of the TUNEL solution or control solution. The
apoptotic thymocytes were analyzed by flow cytometry.
Creatine kinase activity assay
We performed creatine kinase activity assay with a kit according
to the manufacturer’s protocol (Beyotime). 20610
6 thymocytes
were lysed in lysis buffer, and then the creatine kinase activity was
determined by the rate of formation of NADPH from creatine
phosphate using standardised methods [39].
Statistical analysis
Differences between experimental and control results
(mean6SE median) were analyzed by t test. Probability values
of P,0.05 were considered significant.
Supporting Information
Figure S1 Flow cytometric detection of CD69 expression
following TCR stimulation. Total thymocytes and lymphocytes
were stimulated with anti-TCR (10 m/ml) or anti-TCR (10 mg/
ml) and anti-CD28 (10 mg/ml) respectively for 6 h or 12 h or
unstimulated (Unsti-) and then analyzed for CD69 expression.
Found at: doi:10.1371/journal.pone.0005000.s001 (1.18 MB TIF)
Figure S2 The expression pattern of transgenic Ckb. (A)
Thymocytes from CkbTg or littermate mice were stained for
surface CD4, CD8 and intracellular Ckb and then analyzed by
flow cytometry. (B) Transgenic expression of Ckb in DP
thymocytes is comparable with endogenous Ckb expression in
CD4SP thymocytes from littermate controls, shown are two
independent experiments (Exp#1 and Exp #2). Litt, littermate;
CkbTg, Ckb transgenic.
Found at: doi:10.1371/journal.pone.0005000.s002 (1.41 MB TIF)
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DP thymocytes. Total thymocytes from TCR transgenic or Ckb
and TCR double transgenic mice were stained for surface CD4,
CD8 and either CD5 or CD69 and then analyzed by flow
cytometry. Litt, littermate; CkbTg, Ckb transgenic.
Found at: doi:10.1371/journal.pone.0005000.s003 (1.15 MB TIF)
Figure S4 Flow cytometric analysis of lymph node T cell
populations. The percentages of cells within each quadrant are
shown in the upper right quadrant. Litt, littermate; CkbTg, Ckb
transgenic.
Found at: doi:10.1371/journal.pone.0005000.s004 (0.92 MB TIF)
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